SCHEMBL13345547

SCHEMBL13345547

Cc1ccc2c(c1)CCN(CCC(=O)O)C2

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.55
MEN1 O00255 4/20 0.55
GAA P10253 1/20 0.55
USP2 O75604 1/20 0.52
TAAR1 Q96RJ0 1/20 0.52
KDM4E B2RXH2 2/20 0.48
ALOX15 P16050 1/20 0.48
HDAC3 O15379 1/20 0.48
HDAC1 Q13547 1/20 0.48
HDAC8 Q9BY41 1/20 0.48
NCOR2 Q9Y618 1/20 0.48
DRD2 P14416 2/20 0.47
DRD3 P35462 2/20 0.47
SIGMAR1 Q99720 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
S1PR1 P21453 2/20 0.47
HTR1A P08908 1/20 0.46
HTR2A P28223 1/20 0.46
SLC6A4 P31645 1/20 0.46
HTR7 P34969 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15756197 0.94 KMT2A (0.55) KMT2AMEN1GAAUSP2TAAR1
SCHEMBL23011090 0.89 KMT2A (0.55) KMT2AMEN1GAAUSP2TAAR1
SCHEMBL18664437 0.88 DPP8 (0.45) KMT2AMEN1GAAUSP2TAAR1
SCHEMBL24682514 0.85 MEN1 (0.61) KMT2AMEN1GAAUSP2TAAR1
SCHEMBL14421980 0.84 DRD2 (0.51) KDM4EALOX15HDAC3HDAC1HDAC8
SCHEMBL12277163 0.82 PRMT5 (0.45) KMT2AMEN1GAAUSP2TAAR1
SCHEMBL20883859 0.82 MEN1 (0.47) KMT2AMEN1GAAUSP2TAAR1
SCHEMBL12269219 0.82 KMT2A (0.49) KMT2AMEN1GAAUSP2TAAR1
SCHEMBL12706824 0.81 S1PR1 (0.45) KMT2AMEN1GAAUSP2TAAR1
SCHEMBL3477555 0.80 HDAC3 (0.70) KMT2AMEN1USP2TAAR1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2376484-B1 OXADIAZOLE FUSED HETEROCYCLIC DERIVATIVES USEFUL FOR THE TREATMENT OF MULTIPLE SCLEROSIS MERCK SERONO SA (CH) 2015-04-22 EP disclosed
WO-2010069949-A1 OXADIAZOLE FUSED HETEROCYCLIC DERIVATIVES USEFUL FOR THE TREATMENT OF MULTIPLE SCLEROSIS MERCK SERONO S.A. (CH) 2010-06-24 WO disclosed